Innovations for Restoring Missing Bone*

This micro-CE session will focus on the current status of the effect on a precision-fabricated interface to decrease peri-implant disease; updates on the use of photogrammetry to efficiently fabricate a full-arch provisional without an intraoperative pickup as well as combination therapy for augmenting bone defects; and a refined approach for treating bone defects in the esthetic zone.

*Indicates that this activity is approved by AAOMS for continuing dental education credit ONLY.

Learning Objectives

At the conclusion of this program, participants should be able to:

  1. Identify how semiconductor-based nanoscale coatings can be used to enhance bone regeneration around titanium implants. 
  2. Discuss how an in situ tissue engineering approach can be a predictable alternative for the regeneration of large bone defects in the maxillofacial complex.

James C. Melville, DDS, FACS
Associate Professor, University of Texas Health Science Center at Houston
Houston, Texas
Relevant Conflict of Interest Disclosure(s): AxoGen, Inc.: Consultant (Ongoing); Proteocyte AI, Toronto: Consultant (Ongoing)

Simon Young, DDS, MD, PhD, FACS
Associate Professor - Director of Research, University of Texas Health Science Center at Houston
Houston, Texas
Relevant Conflict of Interest Disclosure(s): Amend Surgical: Consultant (Ongoing); KLS Martin: Research Grant or Support (Ongoing); Proteocyte AI, Toronto: Consultant (Ongoing)

An Internet-based CME Activity
Original Release Date: September 21, 2023
Expiration Date: September 21, 2026
Estimated time to complete this educational activity: 0.5 hours
Method of participation: Self-Study

James C. Melville, DDS, FACS

Associate Professor

University of Texas Health Science Center at Houston

James C. Melville, DDS, FACS, is a Professor in the Bernard and Gloria Pepper Katz Department of Oral and Maxillofacial Surgery at the University of Texas Health Science Center at Houston (UTHealth). He specializes in oral, head and neck oncology and microvascular reconstructive surgery. He earned his DDS from University of Michigan and completed a genearl practice residency at the University of California, San Francisco, followed by an oral and maxillofacial surgery residency and fellowships in oncology and microvascular reconstruction at the University of Miami/Jackson Memorial Hospital. Dr. Melville was appointed oral and maxillofacial surgery internship director at UTHealth in 2017 and has received several honors from AAOMS, including the Faculty Educator Development Award in 2019 and the Clinical Research Award in 2023. He served as the President of the Oral and Maxillofacial Section of the American Association for Dental, Oral, and Craniofacial Research (AADOCR)/International Association of Dental Research and was a scientific committee member for the International Academy of Oral Oncology conference. He is a Diplomate and examiner of ABOMS. Dr. Melville has lectured at more than 20 academic institutions, authored over 80 peer-reviewed articles, contributed to 35 textbook chapters and written five textbooks. He serves as a peer reviewer for multiple leading journals.

Disclosure(s): No relevant disclosure to display

Simon Young, DDS, MD, PhD, FACS

Associate Professor, Director of Research

University of Texas Health Science Center at Houston

Simon Young, DDS, MD, PhD, FACS, is Associate Professor and Director of Research in the Department of Oral and Maxillofacial Surgery, The University of Texas Health Science Center at Houston, School of Dentistry. He completed his DDS at the Faculty of Dentistry, University of Toronto, in 2003, his PhD at Rice University, Department of Bioengineering, Houston, Texas, in 2008, and his MD at University of Texas Medical School at Houston in 2011. He subsequently completed first an Oral & Maxillofacial Surgery Residency at University of Texas Health Science Center at Houston and then a Postdoctoral Research Fellowship in Immuno-Engineering at Harvard University, School of Engineering and Applied Sciences. Dr. Young is a Diplomate of the American Board of Oral and Maxillofacial Surgery. He is the author of over 40 articles in peer-reviewed journals and has an NIH-funded laboratory that studies biomaterials-based cancer immunotherapies and maxillofacial tissue engineering.

Disclosure(s): Amend Surgical: Consultant (Ongoing); KLS Martin: Research Grant or Support (Ongoing); Proteocyte AI, Toronto: Consultant (Ongoing)

Continuing Education Provider Approval
The American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider.

ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education.

ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

The American Association of Oral and Maxillofacial Surgeons designates this activity for 0.5 continuing education credit(s).

AGD - Accepted Program Provider
FAGD/MAGD Credit
11/1/22-12/31/26
Provider ID# 214680


Key:

Complete
Failed
Available
Locked
Faculty and Planner Disclosure
Innovations for Restoring Missing Bone
Open to view video.
Open to view video.
Post-Quiz
2 Questions  |  Unlimited attempts  |  2/2 points to pass
2 Questions  |  Unlimited attempts  |  2/2 points to pass
Evaluation
11 Questions
Certificate
0.50 CDE credits  |  Certificate available
0.50 CDE credits  |  Certificate available